Clinical trial to explore treatment effects of Ginkgo biloba Extract EGb 761® in patients with different types of vertigo and effect modification by type of vertigo, chronicity and concomitant pathologies

Trial Profile

Clinical trial to explore treatment effects of Ginkgo biloba Extract EGb 761® in patients with different types of vertigo and effect modification by type of vertigo, chronicity and concomitant pathologies

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 May 2017

At a glance

  • Drugs EGb 761 (Primary)
  • Indications Vertigo
  • Focus Therapeutic Use
  • Sponsors Dr. Willmar Schwabe Pharmaceuticals
  • Most Recent Events

    • 18 Oct 2016 New trial record
    • 17 Oct 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top